Position in LNTH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,593,079
+$4,022,510 QoQ
Shares Held
77,457
+28.5% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#83
of 466 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. LNTH ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in LNTH
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,593,079 | 77,457 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,570,569 | 60,258 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,034,519 | 15,545 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $877,366 | 17,106 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,714,237 | 69,805 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,957,787 | 50,797 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,809,858 | 87,300 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,722,161 | 79,473 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $912,254 | 11,362 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $531,342 | 8,537 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $431,024 | 6,952 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,249,466 | 61,161 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,045,848 | 72,043 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,538,885 | 30,752 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,832,192 | 75,200 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,503,226 | 106,686 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,120,518 | 92,693 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,835,159 | 141,659 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,673,796 | 127,165 | Shares | Sole | 2022-02-08 | |
| 2021-03-31 | $766,029 | 35,846 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $456,960 | 33,874 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||